Rob Stein

Rob Stein appears in the following:

Another COVID surge strikes but vaccines are protecting people from the worst

Friday, May 20, 2022

An even more contagious omicron subvariant is fueling yet another surge of infections in the U.S. The number of hospitalizations is growing.

Comment

In wave after deadly wave, COVID has claimed 1 million lives in the U.S.

Tuesday, May 17, 2022

The virus became the third leading cause of death in the U.S., and caused so many to die in the prime of life that the country experienced the biggest drop in life expectancy since World War II.

Comment

FDA authorizes first COVID booster for children ages 5 to 11

Tuesday, May 17, 2022

The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot.

Comment

Almost 1 million Americans have died from COVID-19

Saturday, May 14, 2022

As the U.S. approaches 1 million COVID-19 deaths, cases and hospitalizations have started rising again, deaths are poised to creep up again, and the nation is on alert for yet another surge.

Comment

Doctors and grief experts on the milestone of 1 million COVID deaths

Thursday, May 12, 2022

President Biden marks the approaching 1 million death toll from COVID in the U.S. More people have died from COVID-19 than died from AIDS in the US since that pandemic began decades ago.

Comment

Biden marks 1 million deaths from COVID-19 in the United States

Thursday, May 12, 2022

President Biden is honoring the loss of at least 1 million deaths from COVID-19 Thursday morning. The ceremony comes as part of an international summit on the pandemic that the White House is hosting.

Comment

Moderna asks FDA to authorize first COVID-19 vaccine for very young children

Thursday, April 28, 2022

The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.

Comment

FDA considers a Pfizer booster and a Moderna vaccine for children

Wednesday, April 27, 2022

Pfizer has asked for authorization for the first booster for children 5 to 11 and Moderna is poised to ask for authorization for the first vaccine for children younger than 5.

Comment

The FDA may soon authorize a COVID booster for kids ages 5 to 11

Tuesday, April 26, 2022

Pfizer and BioNTech are poised to formally ask the Food and Drug Administration to authorize the first COVID booster shot for kids ages 5 to 11.

Comment

Pfizer asks FDA to authorize booster shots for kids ages 5 through 11

Tuesday, April 26, 2022

Data show that a third dose can help boost kids' immunity. Some experts are skeptical that another shot is needed for younger kids.

Comment

The CDC's new forecasting center aims to predict pandemics, just like the weather

Tuesday, April 19, 2022

CDC has unveiled a new pandemic forecasting center, but officials say there's along way to go to make pandemics as predictable as the weather.

Comment

Moderna says its new 'bivalent' vaccine shows promise against COVID variants

Tuesday, April 19, 2022

The company says this version targets both the original coronavirus and the beta variant, and appears to provide broader and longer-lasting protection against different strains, including omicron.

Comment

U.S. life expectancy falls for 2nd year in a row

Thursday, April 07, 2022

The pandemic drove U.S. life expectancy down again in 2021 even though life-saving vaccines were widely available.

Comment

Another booster? A vaccine for omicron? Here's what could be next for COVID vaccines

Monday, April 04, 2022

Federal health officials are convening with outside advisers April 6 to talk about a vaccine plan, whether that's another booster in the fall, an omicron shot or one that targets more than one strain.

Comment

FDA authorizes 4th COVID shots for people 50 and older

Tuesday, March 29, 2022

The Food and Drug Administration has authorize fourth shots for those age 50 and older. The move is aimed at shoring up waning immunity, especially as the U.S. faces the possibility of another surge.

Comment

Does it make sense for older people to get another booster against COVID-19?

Tuesday, March 29, 2022

With the FDA poised to OK another booster for people 50 and older, questions remain: Is the evidence strong enough to warrant a fourth shot, does the timing make sense, and will there be much demand?

Comment

The FDA is expected to authorize 2nd boosters for people 50 and up

Sunday, March 27, 2022

People aged 50 and over could soon be eligible for a second Pfizer-BioNTech or Moderna COVID vaccine booster. The administration wants to offer the shots as immunity from the first booster is waning.

Comment

Moderna edges toward FDA emergency use authorization for pediatric COVID-19 vaccine

Wednesday, March 23, 2022

Moderna says a low-dose version of its vaccine is safe and effective for kids, including those under age 6. The company plans to ask the Food and Drug Administration for emergency authorization.

Comment

Moderna will ask the FDA to approve its COVID-19 vaccine for children under 6

Wednesday, March 23, 2022

Moderna says its low-dose pediatric vaccine appears to be safe and provide protection for kids ages 6 months to 6 years, and it is asking the Food and Drug Administration for emergency authorization.

Comment

U.K. COVID cases are rising. Health officials are watching to see if the U.S. is next

Saturday, March 19, 2022

The rise of the more infectious BA.2 variant in the U.S. — plus signals in the sewage — also point to a possible uptick in cases, and have health officials on alert.

Comment